AAAAAA

   
Results: 1-12 |
Results: 12
VIRTUALLY 100-PERCENT OF MELANOMA CELL-LINES HARBOR ALTERATIONS AT THE DNA LEVEL WITHIN CDKN2A, CDKN2B, OR ONE OF THEIR DOWNSTREAM TARGETS
Authors: WALKER GJ FLORES JF GLENDENING JM LIN AHT MARKL IDC FOUNTAIN JW
Citation: Gj. Walker et al., VIRTUALLY 100-PERCENT OF MELANOMA CELL-LINES HARBOR ALTERATIONS AT THE DNA LEVEL WITHIN CDKN2A, CDKN2B, OR ONE OF THEIR DOWNSTREAM TARGETS, Genes, chromosomes & cancer, 22(2), 1998, pp. 157-163
ANALYSIS OF THE CDKN2A, CDKN2B AND CDK4 GENES IN 48 AUSTRALIAN MELANOMA KINDREDS
Authors: FLORES JF POLLOCK PM WALKER GJ GLENDENING JM LIN AHT PALMER JM WALTERS MK HAYWARD NK FOUNTAIN JW
Citation: Jf. Flores et al., ANALYSIS OF THE CDKN2A, CDKN2B AND CDK4 GENES IN 48 AUSTRALIAN MELANOMA KINDREDS, Oncogene, 15(24), 1997, pp. 2999-3005
LOW-FREQUENCY OF P16 CDKN2A METHYLATION IN SPORADIC MELANOMA - COMPARATIVE APPROACHES FOR METHYLATION ANALYSIS OF PRIMARY TUMORS/
Authors: GONZALGO ML BENDER CM YOU EH GLENDENING JM FLORES JF WALKER GJ HAYWARD NK JONES PA FOUNTAIN JW
Citation: Ml. Gonzalgo et al., LOW-FREQUENCY OF P16 CDKN2A METHYLATION IN SPORADIC MELANOMA - COMPARATIVE APPROACHES FOR METHYLATION ANALYSIS OF PRIMARY TUMORS/, Cancer research, 57(23), 1997, pp. 5336-5347
ARTIFACTUAL STRAIN-SPECIFIC SIGNS OF INCIPIENT BRAIN AMYLOIDOSIS IN APP TRANSGENIC MICE
Authors: ALI SM SIEDLAK SL GONZALEZDEWHITT PA ALTMAN RA GLENDENING JM LOWERY DE SAVAGE MJ POLITES HG PERRY G GREENBERG BD
Citation: Sm. Ali et al., ARTIFACTUAL STRAIN-SPECIFIC SIGNS OF INCIPIENT BRAIN AMYLOIDOSIS IN APP TRANSGENIC MICE, Neurobiology of aging, 17(2), 1996, pp. 223-234
LOSS OF THE P16(INK4A) AND P15(INK4B) GENES, AS WELL AS NEIGHBORING 9P21 MARKERS, IN SPORADIC MELANOMA
Authors: FLORES JF WALKER GJ GLENDENING JM HALUSKA FG CASTRESANA JS RUBIO MP PASTORFIDE GC BOYER LA KAO WH BULYK ML BARNHILL RL HAYWARD NK HOUSMAN DE FOUNTAIN JW
Citation: Jf. Flores et al., LOSS OF THE P16(INK4A) AND P15(INK4B) GENES, AS WELL AS NEIGHBORING 9P21 MARKERS, IN SPORADIC MELANOMA, Cancer research, 56(21), 1996, pp. 5023-5032
MUTATIONS OF THE CDKN2 P16(INK4) GENE IN AUSTRALIAN MELANOMA KINDREDS/
Authors: WALKER GJ HUSSUSSIAN CJ FLORE JF GLENDENING JM HALUSKA FG DRACOPOLI NC HAYWARD NK FOUNTAIN JW
Citation: Gj. Walker et al., MUTATIONS OF THE CDKN2 P16(INK4) GENE IN AUSTRALIAN MELANOMA KINDREDS/, Human molecular genetics, 4(10), 1995, pp. 1845-1852
HOMOZYGOUS LOSS OF THE P15(INK4B) GENE (AND NOT THE P16(INK4) GENE) DURING TUMOR PROGRESSION IN A SPORADIC MELANOMA PATIENT
Authors: GLENDENING JM FLORES JF WALKER GJ STONE S ALBINO AP FOUNTAIN JW
Citation: Jm. Glendening et al., HOMOZYGOUS LOSS OF THE P15(INK4B) GENE (AND NOT THE P16(INK4) GENE) DURING TUMOR PROGRESSION IN A SPORADIC MELANOMA PATIENT, Cancer research, 55(23), 1995, pp. 5531-5535
LOSS OF EXPRESSION OF THE P16 CYCLIN-DEPENDENT KINASE INHIBITOR 2 TUMOR-SUPPRESSOR GENE IN MELANOCYTIC LESIONS CORRELATES WITH INVASIVE STAGE OF TUMOR PROGRESSION/
Authors: REED JA LOGANZO F SHEA CR WALKER GJ FLORES JF GLENDENING JM BOGDANY JK SHIEL MJ HALUSKA FG FOUNTAIN JW ALBINO AP
Citation: Ja. Reed et al., LOSS OF EXPRESSION OF THE P16 CYCLIN-DEPENDENT KINASE INHIBITOR 2 TUMOR-SUPPRESSOR GENE IN MELANOCYTIC LESIONS CORRELATES WITH INVASIVE STAGE OF TUMOR PROGRESSION/, Cancer research, 55(13), 1995, pp. 2713-2718
IS P16 THE GATEKEEPER IN SPORADIC MELANOMA
Authors: FOUNTAIN JW GLENDENING JM FLORES JF WALKER GJ STONE S KAMB A HAYWARD NK ALBINO AP
Citation: Jw. Fountain et al., IS P16 THE GATEKEEPER IN SPORADIC MELANOMA, American journal of human genetics, 57(4), 1995, pp. 226-226
CDKN2 (P16) MUTATIONS IN AUSTRALIAN MELANOMA KINDREDS
Authors: WALKER GJ FLORES JF HUSSUSSIAN CJ GLENDENING JM DRACOPOLI NC HAYWARD NK FOUNTAIN JW
Citation: Gj. Walker et al., CDKN2 (P16) MUTATIONS IN AUSTRALIAN MELANOMA KINDREDS, American journal of human genetics, 57(4), 1995, pp. 426-426
ADVANCED GLYCOSYLATION ENDPRODUCTS CONTRIBUTE TO AMYLOIDOSIS IN ALZHEIMERS-DISEASE
Authors: VITEK MP BHATTACHARYA K GLENDENING JM TONGE P YI YL STOPA E VLASSARA H BUCALA R MANOGUE K CERAMI A
Citation: Mp. Vitek et al., ADVANCED GLYCOSYLATION ENDPRODUCTS CONTRIBUTE TO AMYLOIDOSIS IN ALZHEIMERS-DISEASE, Neurobiology of aging, 15, 1994, pp. 190000079-190000080
ADVANCED GLYCATION END-PRODUCTS CONTRIBUTE TO AMYLOIDOSIS IN ALZHEIMER-DISEASE
Authors: VITEK MP BHATTACHARYA K GLENDENING JM STOPA E VLASSARA H BUCALA R MANOGUE K CERAMI A
Citation: Mp. Vitek et al., ADVANCED GLYCATION END-PRODUCTS CONTRIBUTE TO AMYLOIDOSIS IN ALZHEIMER-DISEASE, Proceedings of the National Academy of Sciences of the United Statesof America, 91(11), 1994, pp. 4766-4770
Risultati: 1-12 |